Study Finds Microplastics in Blood of Heart Attack Patients

BEN STANSALL/AFP via Getty Images/Getty
What Happened
What Happened
Where Sources Agree
- arrows_inputMicroplastics in Heart Patients: Sources align on the detection of microplastics in 84% of heart attack patients compared to 40% of those with chronic coronary syndrome and 32% of controls, noting that polyethylene was the most common plastic identified, according to the European Heart Journal study.
- arrows_inputStudy Limitations Identified: Sources verify that the study's small sample size of 61 patients and its observational design limit the ability to establish a direct causal link, while experts note that contamination concerns and evolving analytical methods require cautious interpretation, according to study authors and external experts.
- arrows_inputEnvironmental Risk Factors: Reports broadly predict that microplastic exposure will be increasingly recognized as a cardiovascular risk factor as study data links smoking and air pollution to higher microplastic concentrations in the blood of heart attack patients, according to study data.
Where Sources Disagree
- arrows_outputValidity of Detection Methods: While study authors present their findings as evidence of microplastics in patient blood, some experts caution that current laboratory methods are unreliable, arguing that researchers may have misidentified endogenous lipids as plastic particles.
- arrows_outputMicroplastic-Heart Attack Link Strength: While study authors report a strong association between microplastics and cardiovascular events, independent experts caution that the small sample size and potential for confounding—particularly regarding smoking—render the current evidence inconclusive.
Timeline
July 15, 2026
Experts call for larger studies: Commentators and the study authors stressed these findings are exploratory and cannot prove causation, urging larger prospective studies, harmonized analytical methods, and detailed exposure assessment; they also recommended considering MNPs alongside modifiable environmental risk factors like air pollution and smoking.
July 14, 2026
Links to smoking, pollution, inflammation: The study found microplastics detection was more frequent among smokers and those with higher PM2.5 exposure, with smoking history the only independent predictor (OR 5.69); STEMI patients also showed elevated inflammatory markers (interleukin‑6 and TNF‑α). However, authors noted limitations including small sample size, cross‑sectional design, potential contamination, and unassessed exposure routes.
July 14, 2026
Higher MNPs in STEMI patients: Researchers detected MNPs in about 84% of patients with ST‑segment elevation myocardial infarction (STEMI), compared with 40% in chronic coronary syndrome (CCS) and ~32% in controls, with higher median concentrations in coronary (~1.2 µg/ml) and peripheral (~1.4 µg/ml) blood and greater polymer diversity (median three polymers) in STEMI cases. Polyethylene was the predominant polymer detected.
Summaries by Ground AI
Sources
See All 38Most Written About
The stories getting the most coverage from the last 24 hours
Timeline
July 15, 2026
Experts call for larger studies: Commentators and the study authors stressed these findings are exploratory and cannot prove causation, urging larger prospective studies, harmonized analytical methods, and detailed exposure assessment; they also recommended considering MNPs alongside modifiable environmental risk factors like air pollution and smoking.
July 14, 2026
Links to smoking, pollution, inflammation: The study found microplastics detection was more frequent among smokers and those with higher PM2.5 exposure, with smoking history the only independent predictor (OR 5.69); STEMI patients also showed elevated inflammatory markers (interleukin‑6 and TNF‑α). However, authors noted limitations including small sample size, cross‑sectional design, potential contamination, and unassessed exposure routes.
July 14, 2026
Higher MNPs in STEMI patients: Researchers detected MNPs in about 84% of patients with ST‑segment elevation myocardial infarction (STEMI), compared with 40% in chronic coronary syndrome (CCS) and ~32% in controls, with higher median concentrations in coronary (~1.2 µg/ml) and peripheral (~1.4 µg/ml) blood and greater polymer diversity (median three polymers) in STEMI cases. Polyethylene was the predominant polymer detected.













